A NOVEL THERAPEUTIC TARGET FOR MITOCHONDRIAL DYSFUNCTION

A Novel Therapeutic Target for Mitochondrial Dysfunction

Mitochondrial dysfunction contributes significantly to a wide range of complex diseases. This impairment in mitochondrial function can lead to cellular failure, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising strategy for addressing this debilitating problem. EPT Fumarate acts by boo

read more